Application of Efgartigimod in Chinese Patients with Myasthenia Gravis: A Single-center Real-world Prospective Study (P1-11.034)
This study aims to evaluate the rapid efficacy and safety of efgartigimod in Chinese myasthenia gravis (MG) population.
Authors
- Wanying Wang (ORCID: https://orcid.org/0009-0006-2300-3601)
- Yongbo Ma (ORCID: https://orcid.org/0009-0009-2676-3923)
- Han Zhou
- Xiuming Guo (ORCID: https://orcid.org/0009-0000-1868-8833)
- Geke Zhu (ORCID: https://orcid.org/0000-0002-6169-1912)
- Xiangtao Nie
- Wenjing Qi
- Lei Hao
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211150
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00